SCHEMBL4767533

SCHEMBL4767533

CCC(NC)C(=O)Nc1c(I)cc(-c2ccc(F)cc2)n(CC(=O)NCc2ccc(F)cc2)c1=O

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.45
LMNA P02545 2/20 0.40
ALDH1A1 P00352 2/20 0.39
TP53 P04637 3/20 0.38
KDM4E B2RXH2 2/20 0.38
RXFP1 Q9HBX9 1/20 0.37
TSHR P16473 3/20 0.37
USP2 O75604 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
THRB P10828 1/20 0.37
KMT2A Q03164 1/20 0.37
ELANE P08246 1/20 0.37
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4774566 0.89 CES2 (0.46) CES2LMNAALDH1A1TP53KDM4E
SCHEMBL4774551 0.84 TSPO (0.43) SMN1; SMN2
SCHEMBL2358720 0.84 ELANE (0.49) CES2ALDH1A1TP53KDM4EELANE
SCHEMBL2358717 0.84 ELANE (0.49) CES2ALDH1A1TP53KDM4EELANE
SCHEMBL3846281 0.72 ELANE (0.50) CES2ALDH1A1KDM4ERXFP1ELANE
SCHEMBL3846277 0.72 ELANE (0.50) CES2ALDH1A1KDM4ERXFP1ELANE
SCHEMBL4770663 0.71 MCHR1 (0.35) LMNAALDH1A1TP53KDM4ERXFP1
SCHEMBL2209970 0.70 F7 (0.49) CES2ALDH1A1TP53KDM4ERXFP1
SCHEMBL2209964 0.70 F7 (0.49) CES2ALDH1A1TP53KDM4ERXFP1
SCHEMBL2317459 0.70 ELANE (0.56) ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1902065-A2 CYCLIC AMIDE DERIVATIVES INHIBITORS OF THE INHIBITOR OF APOPTOSIS PROTEINS, THEIR PREPARATION, AND THEIR USE Novartis AG (CH) 2008-03-26 EP claimed
WO-2006133147-A2 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2006-12-14 WO claimed